CompletedNCT01592110
This study exists to better understand the safety of the medication Injectable and how manageable it feels in practice. Researchers are trying to understand whether the medication Injectable can give earlier or clearer feedback during care.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Zogenix, Inc.
- Condition
- Schizophrenia
CompletedNCT00845026
This study exists to understand how brain scans or other body measurements holds up over time after the earliest research stage. Researchers are trying to understand how people respond to brain scans or other body measurements in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Germany, Mexico, Russian Federation, United States
- Sponsor
- Denovo Biopharma LLC
- Condition
- Schizophrenia
CompletedNCT02411526
This study exists to better understand the safety of a digital app or remote support tool and how manageable it feels in practice. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- Zogenix, Inc.
- Condition
- Schizophrenia
TerminatedNCT01307800
This study exists to compare options and see whether the medication LY2140023 offers something meaningfully different. Researchers are trying to understand whether the medication LY2140023 can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Mexico, United States, Russian Federation, Ukraine
- Sponsor
- Denovo Biopharma LLC
- Condition
- Schizophrenia
WithdrawnNCT05338424
This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 64 Years
- Countries
- United States
- Sponsor
- University of Minnesota
- Condition
- Schizophrenia
CompletedNCT01555697
This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- University of California, San Diego
- Condition
- Schizophrenia
CompletedNCT04173572
This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can make support easier to access outside standard clinic visits.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- University of North Carolina, Chapel Hill
- Condition
- Schizophrenia
TerminatedNCT04103775
This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 15 Years to 100 Years
- Countries
- United States
- Sponsor
- Colorado State University
- Condition
- Schizophrenia
CompletedNCT01354353
This study exists to better understand the safety of the medication Safety and how manageable it feels in practice. Researchers are trying to understand how people respond to the medication Safety in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Denovo Biopharma LLC
- Condition
- Schizophrenia
CompletedNCT01452919
This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand whether a medication treatment can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Greece, United States
- Sponsor
- Denovo Biopharma LLC
- Condition
- Schizophrenia
CompletedNCT03873337
This study exists to see whether smoking support or smoking-related treatment is workable and worth testing more broadly. Researchers are trying to understand whether smoking support or smoking-related treatment can make support easier to access outside standard clinic visits.
SchizophreniaOtherFrom 18 Years to 70 Years
- Countries
- United States
- Sponsor
- Rutgers, The State University of New Jersey
- Condition
- Schizophrenia
TerminatedNCT01328093
This study exists to explore whether the medication LY2140023 could improve care and understanding. Researchers are trying to understand how people respond to the medication LY2140023 in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Austria, Belgium, France, Germany, Poland, United States, Romania, Spain, Sweden
- Sponsor
- Denovo Biopharma LLC
- Condition
- Schizophrenia
CompletedNCT01052103
This study exists to explore whether the medication LY2140023 could improve care and understanding. Researchers are trying to understand whether the medication LY2140023 can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Israel, Italy, Spain, United States
- Sponsor
- Denovo Biopharma LLC
- Condition
- Schizophrenia
CompletedNCT02504151
This study exists to see whether a medication treatment can make care clearer and more responsive. Researchers are trying to understand whether a medication treatment can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Yale University
- Condition
- Schizophrenia
CompletedNCT02686697
This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- Abraham Reichenberg
- Condition
- Schizophrenia
CompletedNCT03576976
This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- New York State Psychiatric Institute
- Condition
- Schizophrenia
TerminatedNCT02739347
This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- United States
- Sponsor
- Baylor College of Medicine
- Condition
- Schizophrenia
CompletedNCT03711500
This study exists to understand what helps a digital app or remote support tool work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- United States
- Sponsor
- New York State Psychiatric Institute
- Condition
- Schizophrenia
CompletedNCT01100775
This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 64 Years
- Countries
- United States
- Sponsor
- University of Maryland, Baltimore
- Condition
- Schizophrenia
CompletedNCT02782442
This study exists to understand how a guided support group holds up over time after the earliest research stage. Researchers are trying to understand whether a guided support group can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- University of Minnesota
- Condition
- Schizophrenia
WithdrawnNCT05140135
This study exists to see whether a therapy or guided support program can play a useful role in care. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- University of Pennsylvania
- Condition
- Schizophrenia
TerminatedNCT03507127
This study exists to explore whether smoking support or smoking-related treatment could improve care and understanding. Researchers are trying to understand whether smoking support or smoking-related treatment can better prevent setbacks and support longer-term stability.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Brown University
- Condition
- Schizophrenia
CompletedNCT04588129
This study exists to learn from real-world information that can show how the medication LB-102 fits into care. Researchers are trying to understand whether the medication LB-102 can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- LB Pharmaceuticals Inc.
- Condition
- Schizophrenia
CompletedNCT03465371
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can better prevent setbacks and support longer-term stability.
SchizophreniaOtherOver 18 Years
- Countries
- United States
- Sponsor
- Center for Social Innovation, Massachusetts
- Condition
- Schizophrenia
TerminatedNCT03838484
This study exists to compare options and see whether smoking support or smoking-related treatment offers something meaningfully different. Researchers are trying to understand whether smoking support or smoking-related treatment can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Vanderbilt University Medical Center
- Condition
- Schizophrenia